Cambium Bio Limited RGS.AX Stock
Cambium Bio Limited Price Chart
Cambium Bio Limited RGS.AX Financial and Trading Overview
| Cambium Bio Limited stock price | 0.01 AUD |
| Previous Close | 0.007 AUD |
| Open | 0.007 AUD |
| Bid | 0.006 AUD x 0 |
| Ask | 0.007 AUD x 0 |
| Day's Range | 0.006 - 0.007 AUD |
| 52 Week Range | 0.006 - 0.07 AUD |
| Volume | 548.89K AUD |
| Avg. Volume | 302.59K AUD |
| Market Cap | 1.84M AUD |
| Beta (5Y Monthly) | -0.276245 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGS.AX Valuation Measures
| Enterprise Value | 3.43M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.4481232 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.433 |
| Enterprise Value/EBITDA | -1.456 |
Trading Information
Cambium Bio Limited Stock Price History
| Beta (5Y Monthly) | -0.276245 |
| 52-Week Change | -86.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 AUD |
| 52 Week Low | 0.006 AUD |
| 50-Day Moving Average | 0.01 AUD |
| 200-Day Moving Average | 0.03 AUD |
RGS.AX Share Statistics
| Avg. Volume (3 month) | 302.59K AUD |
| Avg. Daily Volume (10-Days) | 300.75K AUD |
| Shares Outstanding | 306.44M |
| Float | 181.81M |
| Short Ratio | N/A |
| % Held by Insiders | 41.85% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -442.90% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.031% |
| Return on Equity (ttm) | -611.31% |
Income Statement
| Revenue (ttm) | 533.22K AUD |
| Revenue Per Share (ttm) | 0.002 AUD |
| Quarterly Revenue Growth (yoy) | 41.09% |
| Gross Profit (ttm) | 525.01K AUD |
| EBITDA | -2356659 AUD |
| Net Income Avi to Common (ttm) | -4057413 AUD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.03M AUD |
| Total Cash Per Share (mrq) | 0.003 AUD |
| Total Debt (mrq) | 2.01M AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.556 |
| Book Value Per Share (mrq) | -0.003 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1516614 AUD |
| Levered Free Cash Flow (ttm) | -1414376 AUD |
Profile of Cambium Bio Limited
| Country | Australia |
| State | NSW |
| City | Paddington |
| Address | 2 Paddington Street |
| ZIP | 2021 |
| Phone | 1300 995 098 |
| Website | https://regeneus.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. Its lead platform technology includes Progenza, a multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.
Q&A For Cambium Bio Limited Stock
What is a current RGS.AX stock price?
Cambium Bio Limited RGS.AX stock price today per share is 0.01 AUD.
How to purchase Cambium Bio Limited stock?
You can buy RGS.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cambium Bio Limited?
The stock symbol or ticker of Cambium Bio Limited is RGS.AX.
Which industry does the Cambium Bio Limited company belong to?
The Cambium Bio Limited industry is Biotechnology.
How many shares does Cambium Bio Limited have in circulation?
The max supply of Cambium Bio Limited shares is 306.44M.
What is Cambium Bio Limited Price to Earnings Ratio (PE Ratio)?
Cambium Bio Limited PE Ratio is now.
What was Cambium Bio Limited earnings per share over the trailing 12 months (TTM)?
Cambium Bio Limited EPS is 0 AUD over the trailing 12 months.
Which sector does the Cambium Bio Limited company belong to?
The Cambium Bio Limited sector is Healthcare.